Inhibition of ConA erythroagglutination by alkali-treated lipopolysaccharide.
D003208:Concanavalin A / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004910:Erythrocyte Membrane / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects*; D004926:Escherichia coli; D006384:Hemagglutination / Q000187:drug effects*; D037102:Lectins; D008070:Lipopolysaccharides / Q000494:pharmacology*; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*; D011952:Receptors, Concanavalin A / Q000187:drug effects
D037102:Lectins; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D011952:Receptors, Concanavalin A; D003208:Concanavalin A